Viorele Kit
Product Images NDC 50090-1395

10 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Viorele (NDC 50090-1395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Image 09)

Figure (Image 09)
Chemical structures of the active ingredients Desogestrel and Ethinyl Estradiol, each labeled with their USP designation and molecular formula. The structures show the arrangement of carbon, hydrogen, and oxygen atoms with specific functional groups indicated.*
FDA Label Image

Image02 (Image02)

Image02 (Image02)
A bar graph showing mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45-). It compares four groups: Ever-users (non-smokers), Ever-users (smokers), Controls (non-smokers), and Controls (smokers), with varying mortality rates for each age category.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A forest plot chart showing effect estimates with confidence intervals from various women's health studies comparing 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use.' The X-axis displays effect estimates ranging from -1.50 to 2.00, with data points and horizontal lines representing confidence intervals for odds ratios (OR), relative risks (RR), and hazard ratios (HR) from studies dated 2002 to 2017.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Image05 (Image05)

Image05 (Image05)
Diagram of a 28-pill pack calendar for VIORELE kit, showing a weekly layout from Sunday to Saturday and indicating three types of tablets: white to off-white, light yellow to yellow, and pale green to yellowish green. Arrows guide the sequence to take the tablets across four weeks, with descriptive color identification for each tablet group.*
FDA Label Image

Image06 (Image06)

Image06 (Image06)
An instructional diagram showing how to place a day label on a 28-day oral contraceptive pill kit for VIORELE containing Desogestrel and Ethinyl Estradiol, USP. The image depicts a hand peeling a strip label with weekdays to align it with the corresponding pill placement to track daily medication intake over four weeks.*
FDA Label Image

Logo2 (Logo2)

FDA Label Image

Image03 (Image03)

Image03 (Image03)
Illustration of a 28-pill pack chart showing a weekly tablet schedule with arrows indicating the order of pill intake from Sunday through Saturday across four weeks. The diagram labels three types of tablets by color: white to off-white, light yellow to yellow, and pale green to yellowish green, corresponding to different weeks or doses.*
FDA Label Image

Image04 (Image04)

Image04 (Image04)
An instructional illustration showing a hand peeling a label to place over a weekly oral contraceptive pill kit. The kit layout includes four weeks of circular pill compartments arranged in rows with day labels from Sunday to Saturday. The diagram guides users to place the correct day label for proper pill tracking.*
FDA Label Image

Label Image (Lbl500901395)

Label Image (Lbl500901395)
The VIORELE kit label shows the product containing Desogestrel and Ethinyl Estradiol. It specifies the strength as 0.15 mg and 0.03 mg. The label includes storage instructions to keep the product at 8 to 70 degrees Fahrenheit and notes that the kit contains 28 tablets. The labeler is A-S Medication Solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.